PhRMA Pushes Cost Savings Of Novel Drugs In Japan, Just As New Prices Announced
This article was originally published in PharmAsia News
Executive Summary
Celgene CEO Robert Hugin outlined cost effectiveness of new drugs and met with Japan’s prime minister in his first overseas trip as the new chairman of PhRMA.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.